GRI Bio, Inc. (GRI) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 0.36 |
| Sector P/E (Healthcare) | 21.7 |
GRI overview · GRI earnings · GRI KPIs · GRI investor relations · GRI ownership · GRI peers · GRI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.